Other than that, the SIRT1 activator SRT2104 exhibits promise in mitigating psoriasis symptoms by reducing the expression of genes linked to inflammatory responses and skin cell differentiation, which are IL-17 and TNF-α [18,45,46]. Here, TNF is linked to psoriasis.